The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
1,800
Unnamed facility
Dublin, Ireland
RECRUITINGUnnamed facility
Rotterdam, Netherlands
RECRUITINGCollection of 30-day and 1-year postoperative cardiac events
Time frame: 30-day and 1-year postoperation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.